Table 2.
Clinical characteristics and selected laboratory abnormalities observed in 465 patients infected with SARS‐CoV‐2
| Characteristic | Value | |
|---|---|---|
| Fever | ||
| Any‐no. (%) | 399 (85.81%) | |
| Subgroup‐no. (%) | ||
| ≤38.0 | 215 (53.88%) | |
| 38.1‐39.0 | 148 (37.09%) | |
| >39.0 | 36 (9.02%) | |
| Cough | 312 (67.10%) | |
| Sputum production | 156 (33.55%) | |
| Hemoptysis | 9 (1.94) | |
| Sore throat | 75 (16.13%) | |
| Nasal obstruction | 27 (5.81%) | |
| Muscle ache | 51 (10.97%) | |
| Fatigue | 95 (20.43%) | |
| Shortness of breath | 22 (4.73%) | |
| Diarrhea | 36 (7.74%) | |
| Nausea and vomiting | 22 (4.73%) | |
| Headache | 50 (10.75%) | |
| Blood routine | Patients (n = 465) | |
| Leukocytes (×109/L; normal range 4‐10) | Mean (SD) | 4.97 (1.78) |
| Increased | 7 (1.51%) | |
| Decreased | 149 (32.04%) | |
| Neutrophils (×109/L; normal range 2‐7) | Mean (SD) | 3.40 (3.66) |
| Increased | 15 (3.23%) | |
| Decreased | 94 (20.22%) | |
| Lymphocytes (×109/L; normal range 0.8‐4) | Mean (SD) | 1.24 (0.51) |
| Increased | 0 (0%) | |
| Decreased | 78 (16.77%) | |
| Platelets (×109/L; normal range 83‐303) | Mean (SD) | 184 (62.38) |
| Decreased | 5 (1.08%) | |
| Hemoglobin (g/L; normal range: men 131‐172, women 113‐151) | Mean (SD) | 138.83 (15.81) |
| Decreased | 38 (8.17%) | |
| Hematocrit (%; normal range: men 38‐50.8, women 33.5‐45) | Mean (SD) | 40.88 (4.47) |
| Decreased | 75 (16.13%) | |
| Coagulation function | ||
| International normalized ratio (INR, normal range 0.85‐1.15) | Mean (SD) | 1.05 (0.11) |
| Increased | 69 (14.84%) | |
| Blood biochemistry | ||
| Albumin (g/L; normal range 40‐55) | Mean (SD) | 41.21(4.44) |
| Decreased | 170 (36.56%) | |
| Alanine aminotransferase (U/L; normal range 9‐50) | Mean (SD) | 27.95 (22.49) |
| Increased | 47 (10.11%) | |
| Aspartate aminotransferase (U/L; normal range 15‐40) | Mean (SD) | 28.37(17.56) |
| Increased | 52 (11.18%) | |
| Total bilirubin (µmol/L; normal range 0‐26) | Mean (SD) | 11.52 (7.02) |
| Increased | 13 (27.96%) | |
| Serum sodium (mmol/L; normal range 137‐147) | Mean (SD) | 138.35 (3.65) |
| Increased | 2 (0.43%) | |
| Decreased | 125 (26.88%) | |
| Serum potassium (mmol/L; normal range 3.5‐5.3) | Mean (SD) | 3.82 (0.41) |
| Increased | 1 (0.22%) | |
| Decreased | 89 (19.14%) | |
| Blood urea nitrogen (mmol/L; normal range 3.1‐8) | Mean (SD) | 3.97 (1.60) |
| Increased | 8 (1.72%) | |
| Decreased | 135 (29.03%) | |
| Serum creatinine (µmol/L; normal range: men 57‐97, women 41‐73) | Mean (SD) | 70.43 (25.91) |
| Increased | 57 (12.26%) | |
| Decreased | 28 (6.02%) | |
| Creatine kinase (U/L; normal range 50‐310) | Mean (SD) | 112.93 (180.20) |
| Increased | 23 (4.95%) | |
| Lactate dehydrogenase (U/L; normal range 120‐250) | Mean (SD) | 231.36 (185.08) |
| Increased | 117 (25.16%) | |
| Glucose (mmol/L; normal range 3.9‐6.1) | Mean (SD) | 6.22 (2.13) |
| Increased | 168 (36.13%) | |
| Decreased | 5 (1.08%) | |
| Infection‐related biomarkers | ||
| Procalcitonin (ng/mL; normal range 0‐0.5) | Mean (SD) | 0.06 (0.05) |
| Increased | 0 (0%) | |
| Erythrocyte sedimentation rate (mm/h; normal range: men 0‐15, women 0‐20) | Mean (SD) |
22.69 (19.87) (From 202 patients) |
| Increased | 114 (56.44%) | |
| C‐reactive protein (mg/L; normal range 0‐8) | Mean (SD) | 15.98 (2.16) |
| Increased | 234 (50.32%) | |
| Chest x‐ray/ CT findings | N = 462 | |
| Normal | 54 (11.69%) | |
| Unilateral pneumonia | 99 (21.43%) | |
| Bilateral pneumonia | 177 (38.31%) | |
| Multiple mottling and ground‐glass opacities | 132 (28.57%) | |
Abbreviations: CT, computed tomography; SD, standard deviation.